The company has confirmed they are not going to announce a R/S and the discussion is not even on the table to confirm one. They only wanted the "option" in the proxy for future potential. They will increase the authorized long before they even consider one.
As far as the range. Volume is low, this is the time specific bio funds accumulate with algo's. Only a matter of time here before the next pop north. It's December, loading month.
News 
Market Data 
Discover 
